← Open Payments lookup

KATHERYN FINDLAY: Open Payments

NPI 1104533363 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,482 in 130 payments from 25 companies in 2025. Trend: 2023 $567 · 2024 $1,562 · 2025 $2,482

Food & beverage: $2,482
CompanyPaymentsAmount
ABBVIE INC.26$309
Corcept Therapeutics10$283
GlaxoSmithKline, LLC.14$225
Axsome Therapeutics, Inc.7$222
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$207
AstraZeneca Pharmaceuticals LP7$166
Kowa Pharmaceuticals America, Inc.8$143
Lilly USA, LLC11$137
Exact Sciences Corporation6$130
Novo Nordisk Inc6$129

Products named: Korlym, Auvelity, XIFAXAN, VRAYLAR, ZORYVE, TRELEGY ELLIPTA, MOUNJARO, Cologuard Collection Kit.

Industry payments across TX — which companies pay providers there.